Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Alzheimer's Disease Clinical Trials

A listing of Alzheimer's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (528) clinical trials

If you or someone you love suffers from Mild Cognitive Impairment due to Alzheimer's Disease, or mild Alzheimer's Disease, you may be eligible to participate in a research study.

Phase

ActivMed Practices and Research is looking for volunteers to participate in a device research study on Alzheimer's Disease and memory loss.

Phase N/A

Researchers are conducting a three month study to understand if information collected from digital devices can detect early signs of cognitive change. If eligible, you or someone you care for could contribute to a greater understanding of the early stages of Alzheimer's disease.

Phase N/A

The GRADUATE I clinical study will assess how safe and effective an investigational drug is at slowing the progression of early (also known as ‘prodromal’) or mild Alzheimer’s disease.

Phase

The purpose of this phase 2 research study is to assess safety, tolerability and efficacy of different doses of an investigational medication in treatment of cognitive impairment due to Alzheimer’s Disease.

Phase

XanADu Study Worried about Your Memory? Research has shown that having high levels of cortisol over time is associated with the development of Alzheimer’s disease. Xanamem is designed to block the excess production of cortisol – the stress hormone, in the brain. XanADu is a clinical trial of a drug ...

Phase N/A

The purpose of this study is to determine the safety and efficacy of TRx0237 8 mg/day in the treatment of subjects with mild Alzheimer's Disease compared to placebo.

Phase

This is a Phase II, randomised, multi-centre, double-blind, placebo-controlled proof-of-concept study to assess the safety, tolerability and efficacy of oral Xanamem™ once daily in adult subjects with mild dementia due to AD.

Phase

The rrAD study is testing several strategies that may reduce the risk of Alzheimer’s disease in individuals at risk for the disease when compared to usual care. These strategies include: Aerobic exercise Intensive medical management of blood pressure and cholesterol The combination of these two approaches

Phase